How should I evaluate and manage a patient presenting with diminished deep‑tendon reflexes and lower‑motor‑neuron signs?

Evaluation and Management of Diminished Reflexes with Lower Motor Neuron Signs

When a patient presents with diminished deep tendon reflexes and lower motor neuron signs, you should immediately consider Guillain-Barré syndrome (GBS) as the primary diagnosis if the presentation is acute and progressive, and pursue urgent electrodiagnostic studies and CSF analysis to confirm the diagnosis and initiate treatment. 1

Initial Diagnostic Approach

Key Clinical Features to Assess

The pattern and tempo of symptom onset are critical:

• Acute/subacute progression (days to 4 weeks): This strongly suggests GBS, which classically presents with rapidly progressive symmetrical weakness, sensory signs, and absent or reduced tendon reflexes, typically reaching nadir within 2 weeks 1
• Chronic progression (months to years): Consider chronic inflammatory demyelinating polyneuropathy (CIDP), hereditary motor neuropathies, or multifocal motor neuropathy (MMN) 2, 3

Important caveat: Approximately 10% of GBS patients may present with normal or even hyperactive reflexes throughout their clinical course, particularly those with acute motor axonal neuropathy (AMAN) variant and anti-ganglioside antibodies (GM1, GM1b, GD1a, or GalNAc-GD1a) 4. Do not exclude GBS based solely on preserved reflexes.

Specific Clinical Patterns to Identify

Examine for these GBS variants 1:

• Classic sensorimotor GBS (30-85% of cases): Symmetrical weakness with sensory signs
• Pure motor variant (5-70%, up to 70% in Bangladesh): Motor weakness without sensory involvement
• Miller Fisher syndrome (5-25%): Ophthalmoplegia, ataxia, and areflexia
• Pharyngeal-cervical-brachial: Bulbar and upper limb weakness sparing legs
• Paraparetic: Weakness restricted to legs

Essential Ancillary Investigations

Electrodiagnostic Studies

Perform nerve conduction studies (NCS) and electromyography (EMG) urgently in all patients with suspected acute lower motor neuron syndrome:

• These studies distinguish demyelinating from axonal pathology 2
• In patients with clinically normal reflexes but suspected polyneuropathy, electromyographically recorded deep tendon reflexes (Er-DTR) detect abnormalities in 60% of cases where clinical examination appears normal 5
• Er-DTR latencies >150% of normal mean indicate demyelination 5

Cerebrospinal Fluid Analysis

Obtain CSF examination looking for:

• Albuminocytological dissociation (elevated protein with normal cell count): Classic finding in GBS, though may not be present in the first week 1
• Elevated cell count should prompt consideration of alternative diagnoses (infection, malignancy, sarcoidosis)

Laboratory Testing

Order the following to exclude mimics and identify treatable causes 1, 2:

• Complete blood count, glucose, electrolytes, kidney and liver function
• Anti-ganglioside antibodies (GM1, GD1a, GQ1b): Positive in many GBS cases, especially AMAN and Miller Fisher syndrome
• Consider anti-GM1 IgM antibodies for MMN if pattern is asymmetric motor-only weakness 3

Specialized Testing for Specific Scenarios

Autonomic testing should be considered when 2:

• Small fiber involvement is suspected (burning pain, allodynia, erythromelalgia)
• Autonomic symptoms are prominent (orthostatic hypotension, abnormal sweating, cardiac rhythm disturbances)
• Use a battery of validated tests including heart rate variability for highest diagnostic accuracy

Skin biopsy for intraepidermal nerve fiber density may be considered for suspected small fiber sensory polyneuropathy when standard NCS are normal 2

Critical Differential Diagnoses to Exclude

Watch for red flags suggesting alternative diagnoses 1:

• Asymmetric weakness: Consider MMN, vasculitic neuropathy, or mononeuropathy multiplex
• Upper motor neuron signs (sustained clonus, marked spasticity): Suggests spinal cord pathology, though rare GBS cases can have extensor plantar responses 6
• Marked sensory level: Indicates myelopathy, not peripheral neuropathy
• Bladder dysfunction at onset: Uncommon in GBS; consider spinal cord lesion
• Fever and meningismus: Suggests infectious or inflammatory CNS process
• Severe persistent asymmetric weakness: Consider stroke, focal CNS lesion

Management Priorities

For Acute Progressive Cases (Suspected GBS)

Initiate treatment urgently if GBS is confirmed, as early intervention improves outcomes:

• Intravenous immunoglobulin (IVIG) is the standard treatment
• Avoid corticosteroids in typical GBS—they are ineffective and may worsen outcomes 6
• Monitor respiratory function closely; approximately 20-30% require mechanical ventilation
• Watch for autonomic instability (cardiac arrhythmias, blood pressure fluctuations)

For Chronic or Immune-Mediated Cases

• CIDP: Responds to IVIG, corticosteroids, or plasma exchange
• MMN: Requires IVIG; notably does NOT respond to corticosteroids 3, 7

Common Pitfall

The most critical error is delaying diagnosis and treatment in atypical GBS presentations—particularly those with preserved reflexes, pure motor involvement, or regional variants. Maintain high clinical suspicion and proceed with confirmatory testing even when the presentation doesn't fit the classic pattern perfectly 4.